Normalization of total bilirubin after switch from elexacaftor/tezacaftor/ivacaftor to vanzacaftor/tezacaftor/deutivacaftor in patients with cystic fibrosis and Gilbert’s syndrome
Normalization of total bilirubin after switch from elexacaftor/tezacaftor/ivacaftor to vanzacaftor/tezacaftor/deutivacaftor in patients with cystic fibrosis and Gilbert’s syndrome. // Journal of Cystic Fibrosis. – URL: https://www.sciencedirect.com/science/article/pii/S1569199326016528?dgcid=rss_sd_all
Normalization of total bilirubin after switch from elexacaftor/tezacaftor/ivacaftor to vanzacaftor/tezacaftor/deutivacaftor in patients with cystic fibrosis and Gilbert’s syndrome. Journal of Cystic Fibrosis. https://www.sciencedirect.com/science/article/pii/S1569199326016528?dgcid=rss_sd_all
“Normalization of total bilirubin after switch from elexacaftor/tezacaftor/ivacaftor to vanzacaftor/tezacaftor/deutivacaftor in patients with cystic fibrosis and Gilbert’s syndrome.” Journal of Cystic Fibrosis.
@article{article53317,
title = {Normalization of total bilirubin after switch from elexacaftor/tezacaftor/ivacaftor to vanzacaftor/tezacaftor/deutivacaftor in patients with cystic fibrosis and Gilbert’s syndrome},
journal = {Journal of Cystic Fibrosis},
url = {https://www.sciencedirect.com/science/article/pii/S1569199326016528?dgcid=rss_sd_all}
}
ABSTRACT Aim To investigate the longitudinal association between early‐life movement behaviour patterns and later clinically diagnosed obesity. Method In the population‐based All Babies in Southeast Sweden (ABIS) cohort, 16 415 children...